Therapeutic effect of mosapride and lansoprazole for the prevention of aspiration pnumonia in patiets treated by gastrostomy feeding

Therapeutic effect of mosapride and lansoprazole for the prevention of aspiration pnumonia in patiets treated by gastrostomy feeding - Prevention of aspiration pnumonia

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000002240

Enrollment

150

Registered

2009-08-01

Start date

2009-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patients treated by gastrostomy feeding

Interventions

mosapride administration lansoprazole administration control

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients with chronic gastritis and esophagitis who are treated by gastrostomy feeding

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
occurence of aspiration pnumonia	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026